| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 820.77M | 257.93M | 204.77M | -415.21M | 1.06B |
| Gross Profit | 778.67M | 257.93M | 204.77M | -415.21M | 1.06B |
| EBITDA | 794.87M | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 230.50M | 176.06M | 126.10M | -513.07M | 670.11M |
Balance Sheet | |||||
| Total Assets | 15.81B | 13.12B | 12.93B | 13.40B | 15.41B |
| Cash, Cash Equivalents and Short-Term Investments | 278.58M | 84.11M | 221.68M | 264.60M | 385.74M |
| Total Debt | 13.07B | 10.01B | 10.11B | 10.61B | 11.08B |
| Total Liabilities | 13.24B | 10.59B | 10.37B | 10.74B | 11.67B |
| Stockholders Equity | 2.57B | 2.53B | 2.56B | 2.67B | 3.74B |
Cash Flow | |||||
| Free Cash Flow | -248.88M | 205.67M | 213.27M | 325.72M | 519.18M |
| Operating Cash Flow | -248.88M | 205.67M | 213.27M | 325.72M | 519.18M |
| Investing Cash Flow | -23.19M | 178.22M | 551.75M | 509.84M | 2.55B |
| Financing Cash Flow | 0.00 | -521.58M | -807.94M | -956.70M | -2.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | $1.03B | 7.75 | 9.59% | 14.90% | 5.52% | -47.72% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | $1.58B | 9.59 | 9.23% | 11.37% | 70.94% | 2.95% | |
57 Neutral | $1.14B | 6.08 | 15.59% | 20.03% | 72.30% | -54.02% | |
55 Neutral | $1.08B | 12.61 | 6.67% | 12.69% | -15.48% | -36.45% | |
53 Neutral | $1.15B | 8.01 | 9.04% | 11.40% | 9.46% | -111.44% | |
45 Neutral | $1.18B | -2.29 | -23.25% | 14.29% | 22.48% | 50.49% |
On February 11, 2026, Chimera Investment Corporation’s board declared a first-quarter 2026 cash dividend of $0.45 per common share, raising the payout from the fourth quarter 2025 level of $0.37. The common dividend will be paid on April 30, 2026 to shareholders of record as of March 31, 2026, with the same date set as the ex-dividend date.
The board also declared first-quarter 2026 cash dividends on all four series of its preferred stock, including $0.50 per share on its 8.00% Series A and floating-rate payouts of $0.6078, $0.5423, and $0.5820 per share on its Series B, C, and D issues, respectively. These preferred dividends, reflecting coupon rates tied to three-month CME Term SOFR plus applicable spreads, are payable on March 30, 2026 to holders of record on March 2, 2026, highlighting Chimera’s ongoing distribution to both common and preferred shareholders.
The most recent analyst rating on (CIM) stock is a Hold with a $13.50 price target. To see the full list of analyst forecasts on Chimera Investment stock, see the CIM Stock Forecast page.
On December 18, 2025, Chimera Investment Corporation announced that its board of directors had declared a fourth-quarter 2025 cash dividend of $0.37 per share of common stock, reinforcing its ongoing capital-return strategy to shareholders. The dividend is scheduled to be paid on January 30, 2026, to common stockholders of record as of December 31, 2025, with the same date serving as the ex-dividend date, signaling continued confidence in the company’s earnings capacity and cash flow generation from its diversified mortgage-focused investment portfolio.
The most recent analyst rating on (CIM) stock is a Hold with a $13.00 price target. To see the full list of analyst forecasts on Chimera Investment stock, see the CIM Stock Forecast page.